X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19344) 19344
Book Review (3264) 3264
Publication (2028) 2028
Book Chapter (169) 169
Book / eBook (131) 131
Conference Proceeding (50) 50
Newsletter (30) 30
Magazine Article (16) 16
Newspaper Article (6) 6
Dissertation (5) 5
Trade Publication Article (2) 2
Data Set (1) 1
Paper (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18097) 18097
animals (12227) 12227
humans (11731) 11731
mice (7386) 7386
female (5628) 5628
male (4561) 4561
immunology (3996) 3996
proteins (3772) 3772
recombinant fusion proteins - genetics (3353) 3353
recombinant fusion proteins - administration & dosage (2455) 2455
recombinant fusion proteins - metabolism (2418) 2418
expression (2409) 2409
recombinant fusion proteins - immunology (2318) 2318
biotechnology & applied microbiology (2285) 2285
mice, inbred balb c (2184) 2184
biochemistry & molecular biology (2154) 2154
recombinant fusion proteins - therapeutic use (2109) 2109
research (2101) 2101
medicine, research & experimental (2065) 2065
analysis (2003) 2003
vaccines (1938) 1938
recombinant proteins (1923) 1923
gene expression (1899) 1899
health aspects (1861) 1861
rats (1842) 1842
oncology (1780) 1780
antibodies (1684) 1684
in-vivo (1651) 1651
cancer (1641) 1641
mice, inbred c57bl (1635) 1635
recombinant (1626) 1626
middle aged (1598) 1598
antigens (1591) 1591
molecular sequence data (1561) 1561
immunization (1557) 1557
pharmacology & pharmacy (1543) 1543
cell line (1462) 1462
amino acid sequence (1461) 1461
cell biology (1456) 1456
recombinant fusion proteins - pharmacology (1455) 1455
adult (1444) 1444
research article (1442) 1442
multidisciplinary sciences (1413) 1413
treatment outcome (1396) 1396
microbiology (1326) 1326
disease models, animal (1314) 1314
recombinant proteins - genetics (1310) 1310
medicine (1308) 1308
cells (1305) 1305
vaccination (1260) 1260
abridged index medicus (1248) 1248
physiological aspects (1219) 1219
immunotherapy (1211) 1211
care and treatment (1161) 1161
aged (1142) 1142
cell line, tumor (1138) 1138
article (1131) 1131
hematology (1123) 1123
therapy (1103) 1103
protein (1102) 1102
biotechnology (1096) 1096
fusion protein (1083) 1083
cells, cultured (1082) 1082
recombinant proteins - immunology (1076) 1076
peptides (1064) 1064
recombinant proteins - metabolism (1046) 1046
genetic vectors (1045) 1045
vaccine (1042) 1042
science (1010) 1010
infection (997) 997
enzyme-linked immunosorbent assay (996) 996
immune response (988) 988
viruses (970) 970
transfection (963) 963
time factors (926) 926
virology (920) 920
infectious diseases (906) 906
escherichia-coli (903) 903
genetic aspects (902) 902
immunogenicity (897) 897
recombinant fusion proteins - chemistry (897) 897
t cells (897) 897
apoptosis (884) 884
recombinant fusion proteins - biosynthesis (864) 864
base sequence (855) 855
recombinant proteins - therapeutic use (847) 847
recombinant proteins - administration & dosage (846) 846
dose-response relationship, drug (840) 840
cytokines (839) 839
gene therapy (839) 839
genetic engineering (838) 838
vaccines, synthetic - immunology (828) 828
biology (825) 825
protein binding (820) 820
recombinant proteins - pharmacology (816) 816
rodents (802) 802
immunity (800) 800
infections (799) 799
genes (789) 789
genetics & heredity (783) 783
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (77) 77
UofT at Mississauga - Stacks (26) 26
UofT at Scarborough - Stacks (17) 17
UTL at Downsview - May be requested (16) 16
Engineering & Comp. Sci. - Stacks (11) 11
St. Michael's College (John M. Kelly) - 2nd Floor (8) 8
Robarts - Stacks (7) 7
St. Augustine's Seminary - Stacks (7) 7
Law (Bora Laskin) - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Online Resources - Online (4) 4
Earth Sciences (Noranda) - Stacks (3) 3
Regis College - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Gerstein Science - Searching (1) 1
OISE - Missing (1) 1
Physics - Missing (1) 1
Physics - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Not Returned (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19430) 19430
Chinese (67) 67
German (31) 31
French (25) 25
Spanish (22) 22
Japanese (21) 21
Russian (10) 10
Polish (7) 7
Italian (4) 4
Czech (3) 3
Danish (1) 1
Hebrew (1) 1
Korean (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 06/2014, Volume 123, Issue 25, pp. 3855 - 3863
Journal Article
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 06/2015, Volume 13, Issue 6, pp. 967 - 977
Prophylactic factor replacement, which prevents hemarthroses and thereby reduces the musculoskeletal disease burden in children with hemophilia A, requires... 
coagulation factor | hemophilia A | recombinant fusion proteins | VIII | children | prophylaxis | Children | Coagulation factor VIII | Recombinant fusion proteins | Hemophilia A | Prophylaxis | Recombinant Fusion Proteins - immunology | Factor VIII - immunology | Hemarthrosis - diagnosis | Age Factors | Recombinant Fusion Proteins - adverse effects | Factor VIII - pharmacokinetics | Humans | Child, Preschool | Half-Life | Male | Immunoglobulin Fc Fragments - administration & dosage | North America | Hemarthrosis - blood | Immunoglobulin Fc Fragments - immunology | China | Coagulants - administration & dosage | Factor VIII - adverse effects | Female | Hemophilia A - prevention & control | Coagulants - pharmacokinetics | Hemophilia A - diagnosis | Child | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | Severity of Illness Index | Drug Administration Schedule | Europe | Risk Factors | Treatment Outcome | Hemophilia A - blood | Hemarthrosis - drug therapy | Recombinant Fusion Proteins - pharmacokinetics | Factor VIII - administration & dosage | South Africa | Infusions, Intravenous | Australia | Coagulants - adverse effects | Coagulants - immunology | Hemarthrosis - prevention & control | Hemophilia A - drug therapy | Antibodies, Neutralizing - blood | Prevention | Proteins | Care and treatment | Blood coagulation factor VIII | Hemophilia | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 13, pp. 3031 - 3037
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 02/2015, Volume 104, Issue 2, pp. 705 - 713
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 3, pp. 524 - 532
Highlights ► This Phase 1 trial evaluated the safety and immunogenicity of an RSV (F) nanoparticle vaccine. ► The vaccine was well-tolerated and no related... 
Allergy and Immunology | Respiratory syncytial virus (RSV) | Palivizumab | Fusion protein (F protein) | Competitive ELISA | SF9 insect cell | Microneutralization | Aluminum phosphate | Anti-F IgG | Nanoparticle vaccine | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | IMMUNE GLOBULIN | COTTON RATS | INFLUENZA | RISK | IMMUNOLOGY | F-GLYCOPROTEIN | INFANTS | INFECTION | YOUNG-CHILDREN | Recombinant Fusion Proteins - immunology | Single-Blind Method | Biotechnology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Aluminum Compounds - adverse effects | Phosphates - administration & dosage | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Nanoparticles - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Young Adult | Respiratory Syncytial Virus Vaccines - adverse effects | Sf9 Cells | Technology, Pharmaceutical | Vaccines, Virosome - immunology | Vaccines, Synthetic - adverse effects | Placebos - adverse effects | Adult | Female | Placebos - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Vaccines, Virosome - genetics | Animals | Aluminum Compounds - administration & dosage | Phosphates - adverse effects | Vaccines, Virosome - adverse effects | Respiratory Syncytial Virus Vaccines - administration & dosage | Adolescent | Recombinant Fusion Proteins - genetics | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Respiratory Syncytial Virus Vaccines - genetics | Antibodies, Neutralizing - blood | Virus diseases | Phosphates | Vaccines | Immunoglobulin G | Enzyme-linked immunosorbent assay | Proteins | Nanoparticles | Infections | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1193 - 1203
Journal Article